Skip to main content
. 2023 Dec 19;16(1):7. doi: 10.3390/pharmaceutics16010007

Figure 5.

Figure 5

Inorganic NPs applied for nano-DDS formation in OC therapy. Reproduced with permission from ref. [185] (opyright 2023 Elsevier), ref. [42] (Copyright 2023 Elsevier), ref. [186] (Copyright 2023 Elsevier), ref. [21] (Copyright 2019 Elsevier), and ref. [102] (Copyright 2023 Elsevier).